Mark C. Schiller - Jan 9, 2025 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Chief Legal Officer
Signature
/s/ Marc Belsky, Attorney-in-Fact
Stock symbol
KZR
Transactions as of
Jan 9, 2025
Transactions value $
$0
Form type
4
Date filed
1/13/2025, 04:15 PM
Previous filing
Jul 26, 2024
Next filing
Mar 5, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Award $0 +24.5K $0.00 24.5K Jan 9, 2025 Common Stock 24.5K $6.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on February 9, 2025, subject to the Reporting Person continuing to provide service through each such date.